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Background: Acute fulminant myocarditis can result in a rapidly progressive and fatal course in children. Mechanical circulatory support provides 
a life-saving treatment strategy allowing for both recovery of ventricular function, and bridge to transplantation. We report our single institutional 
experience using mechanical circulatory support in children with myocarditis.
Methods: A retrospective review of all patients undergoing mechanical circulatory support from 1995 to 2009 was performed. Mechanical support 
included ventricular assist device (VAD) and/or extracorporeal membranous oxygenation (ECMO). Patients with a clinical history, clinical findings, 
blood analysis, and/or endomyocardial biopsy (EMB) findings consistent with myocarditis were included.
Results: A total of 16 children were identified with myocarditis. Viral pathogens were isolated in 10/16 patients (Parvovirus B19=7, Enterovirus=1, 
CMV=1, EBV=1). Presenting symptoms included: fatigue (7/16), chest pain (3/16), abdominal pain (3/16), and upper respiratory symptoms 
(3/16). Four patients had one or more device changes during the course of therapy yielding a total of 21 device implantations. Types of device 
therapy included: Biomedicus LVAD (6/21), DeBakey MicroMed (2/21), Thoratec LVAD (1/21), Heartmate II (2/21), Rotoflow (1/21), Tandem Heart 
(1/21), and ECMO (8/21). The median age at implantation was 6 years (range 13 days - 16 years) with a median weight of 20.2 kg (range 2.7 - 93 
kg). Median duration of device therapy was 117 hours (range 52 - 3312 hours). Bridge to recovery or orthotopic heart transplant (OHT) occurred 
in 13/16 patients. Bridge to recovery was seen in 7/16 patients. In these patients echocardiographic assessment of left ventricular function by 
ejection fraction was made pre- and post-assist, and revealed significant improvement (20% vs. 62%; p= 0.0004).
Conclusion: Mechanical circulatory support is a successful treatment strategy in children with acute fulminant myocarditis. Echocardiographic 
parameters such as ejection fraction can be used to predict recovery of ventricular function. Bridge to recovery or OHT is seen in the majority of 
pediatric patients with myocarditis.
